Case studies have reported strong nuclear accumulation of p53 in the sarcomatoid regions of the tumor, consistent with oncogenic dominant-negative or gain-of-function mutations in p53 [28], whereas adenocarcinoma typically lacks strong p53 staining [29, 30]. The gene discussed is TP53; the disease is neoplasm.